FDA-Drug2013-05-22Class I
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
Gilead Sciences, Inc.
Hazard
Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
Sold states
Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.
Affected count
3,181 vials
Manufactured in
333 Lakeside Drive, Foster City, CA, United States
Products
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-324-2013Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief